New closed-tube LAMP assay targets rapid FHV-1 detection
Bottom line
Researchers have reported a new closed one-tube LAMP assay for feline herpesvirus-1, a common cause of feline upper respiratory tract disease, that aims to make molecular testing faster and more practical outside reference labs. In the new Animals paper, the assay targets the FHV-1 thymidine kinase gene, runs at 63 °C, delivers a visual color change from violet to yellow or a fluorescent readout in about 40 minutes, and detected as few as 100 copies without cross-reacting with other feline respiratory pathogens. In testing on 87 clinical nasal swabs, it identified 44 positives and showed 97.7% overall agreement with TaqMan qPCR, according to the study record. (agris.fao.org)
Why it matters: For veterinary teams, the main appeal is workflow. A closed-tube format can help reduce amplicon contamination risk, which is a known limitation of some open-tube isothermal assays, while still offering a visual, point-of-care-friendly result. That could be useful in primary care hospitals, shelters, breeding settings, or field work where PCR access is limited, especially because FHV-1 remains a major contributor to feline respiratory disease and diagnostic interpretation often needs to balance speed, cost, and the fact that herpesvirus-positive cats may be carriers or intermittent shedders rather than the sole cause of current signs. (frontiersin.org)
What to watch: The next question is whether this assay moves beyond proof-of-concept into broader validation, commercialization, or head-to-head testing against existing in-clinic and reference-lab respiratory diagnostics. (agris.fao.org)
Key facts
- Study type
- Closed one-tube colorimetric and fluorescent LAMP assay
- Target
- Feline herpesvirus-1 thymidine kinase gene
- Run conditions
- 63 °C for about 40 minutes
- Readout
- Visual color change from violet to yellow, or fluorescent readout
- Analytical sensitivity
- Detected as few as 100 copies
- Cross-reactivity
- No cross-reactivity with related feline respiratory pathogens
- Clinical testing
- 87 clinical nasal swabs, with 44 positives
- Agreement with comparator
- 97.7% overall agreement with TaqMan qPCR
- Clinical context
- Feline herpesvirus-1 is a common cause of feline upper respiratory tract disease
A newly reported closed one-tube colorimetric and fluorescent LAMP assay could expand the diagnostic toolkit for feline herpesvirus-1 by pushing molecular detection closer to the exam room. In the Animals study, researchers developed a thymidine kinase gene-targeted assay that can be read either by naked-eye color change or fluorescence, with a total run time of about 40 minutes at 63 °C. The study record says the test detected 100 copies, showed no cross-reactivity with related pathogens, and reached 97.7% agreement with TaqMan qPCR on 87 clinical nasal swabs. (agris.fao.org)
The paper lands as interest grows in isothermal amplification for veterinary diagnostics, particularly for settings that need faster answers without full PCR infrastructure. A separate 2026 review in Frontiers in Veterinary Science noted that LAMP platforms are drawing attention for field and point-of-need use, but also flagged a practical drawback: LAMP generates large amounts of amplicon, so assays that require opening tubes for downstream readout can increase contamination risk. That concern is directly relevant here, because the new FHV-1 assay is designed as a closed one-tube system. (frontiersin.org)
There’s also a notable through-line in the authors’ work. On July 6, 2026, Frontiers in Veterinary Science published a related study from overlapping authors describing a LAMP-lateral flow dipstick assay for FHV-1. That assay also targeted the TK gene, ran at 63 °C for 40 minutes, and was evaluated on 87 nasal swabs from cats with suspected upper respiratory disease. In that study, the assay showed 91.30% sensitivity, 97.56% specificity, and 94.25% overall agreement versus qPCR, while the authors emphasized its suitability for primary veterinary hospitals and field settings. Taken together, the two papers suggest a broader push to build simpler, visual FHV-1 diagnostics in multiple formats. (frontiersin.org)
That matters because FHV-1 is a familiar but still frustrating pathogen in feline practice. It’s a major cause of feline upper respiratory disease, and infection commonly becomes lifelong, with latent infection and intermittent shedding complicating both case management and test interpretation. Reviews and guidelines note that PCR can document FHV-1, but a positive result does not always prove that the virus is driving the cat’s current illness, since healthy carriers and low-level shedders can also test positive. (journals.sagepub.com)
No outside expert commentary specific to this new Animals paper was readily available at publication, but the broader diagnostic literature helps frame the industry view: clinicians want tests that are faster, cheaper, and easier to deploy, yet still reliable enough to support triage and infection-control decisions. Isothermal methods fit that need well when they maintain specificity and avoid contamination problems. That’s why the closed-tube design may be the most practice-relevant feature here, beyond the assay’s analytical performance. (frontiersin.org)
Why it matters: For veterinary professionals, this is less about replacing qPCR outright and more about where rapid molecular screening could fit in real-world feline respiratory workups. In clinics without ready access to same-day PCR, a 40-minute closed-tube assay could help support decisions on isolation, client communication, outbreak management in shelters or catteries, and whether FHV-1 should stay high on the differential list. But interpretation will still require clinical context, because FHV-1 test positivity alone doesn’t cleanly separate active disease from carriage or recrudescence. (agris.fao.org)
The study also reflects a larger shift in companion animal diagnostics toward decentralized testing. Recent veterinary literature describes growing use of LAMP, lateral flow, and other isothermal platforms across animal infectious diseases because they can tolerate simpler equipment and support point-of-care deployment. If these FHV-1 assays continue to perform well in broader field validation, they could become part of that same movement in feline medicine. (frontiersin.org)
What to watch: The next milestones are straightforward: full-text publication details and uptake of the Animals paper, independent validation in larger and more diverse cat populations, and any move toward commercial kits or integration into clinic-side respiratory testing workflows. The related Frontiers paper, published July 6, 2026, suggests this research group is actively iterating on FHV-1 point-of-care formats, so follow-on studies may come quickly. (frontiersin.org)